Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days
Centre Hospitalier Universitaire De Caen Normandie has 1 pending office action in the Biotechnology & Pharmaceuticals technology area. This action is being handled by 1 distinct examiner and 1 distinct art unit, concentrating the company's current legal focus. This singular focus indicates that the company's active patent prosecution is limited to one specific technical area.
BAEK, JONGHWAN NMN is the busiest examiner, responsible for the 1 pending office action. This single examiner's review will determine the outcome for the company's only currently active office action. Without other pending cases, the company cannot leverage multiple examiner relationships to advance its intellectual property goals.
Practitioners should note that the 1 pending office action is the only matter currently requiring attention from the company. Because this action is assigned to 1 distinct art unit, the prosecution must strictly adhere to the technical and procedural norms of that specific group. The company's immediate path to allowance is entirely dependent on the assessment provided by BAEK, JONGHWAN NMN.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Double-patenting + other | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| BAEK, JONGHWAN NMN | 1 | 50.0% | +0.0% |
| Art Unit | Apps |
|---|---|
| 1618 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18291677 | SELF-ASSEMBLED BIOCOMPATIBLE IMAGING PARTICLES, THEIR SYNTHESIS AND THEIR USE IN IMAGING TECHNIQUES | BAEK, JONGHWAN NMN | 1618 | §103§112DP | Non-Final OA | — | Pending | Jan 24, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialCentre Hospitalier Universitaire De Caen Normandie has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
Jonghwan Nmn Baek has the most, with 1 of Centre Hospitalier Universitaire De Caen Normandie's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
